JNJ-41443532

· Johnson & Johnson Pharmaceutical Research and Development, L.L.C.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for JNJ-41443532, covering 2013-12-11 to 2014-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of Single and Multiple Ascending Doses of JNJ-41443532 in Healthy Male Participants [Phase 1]

See pricing